Research Papers

25 of 535 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Invasive Aspergillosis and Candidiasis in a Patient with Plasma Cell Myeloma
Khadwal A; Gupta K; Mallik N; Sharma M; Malhotra P.
Turk J Haematol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Management of Relapsed Hodgkin Lymphoma During the Second Trimester of Pregnancy: Case Report.
Yaman F; Andıç N; Davutoğlu NO; Üsküdar Teke H; Gündüz E.
Turk J Haematol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Oxidative and Fibrinolytic Mechanisms: Two Important Processes to Consider in Platelet Storage
Garcia-Bañuelos JJ; Galicia-Moreno M; Monroy-Ramirez HC; Navarro-Partida J; Bastidas-Ramirez BE; Santos A; Armendariz-Borunda J.
Turk J Haematol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Circular RNA PVT1 Regulates Cell Proliferation, Migration, and Apoptosis by Stabilizing c-Myc and Downstream Target CXC…
Sheng XF; Hong LL; Fan L; Zhang Y; Chen KL; Mu J; Shen SY; Zhuang HF.
Turk J Haematol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Circulating Histiocytes and Hemophagocytosis in Peripheral Blood
Jaziri H; Dhaha Y; Bergaoui A; Bouatay A.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A Novel Inclusion Body in Acute Promyelocytic Leukemia
Dong SX; Liu J; Ru YX.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for <i>CSF3R T618I</i> Mutant Chro…
Ye P; Lin Q; Jin M; Gu X; Lu Y.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Short-Term Clinical Outcomes of Packed Red Blood Cell Transfusions with Isolated Enzyme-Phase Crossmatch Incompatibilit…
Yılmaz U; Yaşar A; Öngören Ş; Başlar Z; Ar MC.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Erratum
NA
Turk J Haematol (Unknown)
Published: 2022
1/6 Transparent
Successful Haploidentical Hematopoietic Stem Cell Transplantation with Azacitidine and Venetoclax Maintenance Therapy f…
Yuan J; Pei R; Lu Y.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Circulating CD133+/–CD34– Have Increased c-<i>MYC</i> Expression in Myeloproliferative Neoplasms
Uslu Bıçak İ; Tokcan B; Yavuz AS; Tokdemir SS.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Primary Natural Killer/T-Cell Lymphoma of the Ribs
Kim KM; Jang KY; Kwak JY; Ahn AR.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Sickle Cell Leg Ulcer Extending to the Achilles Tendon
Asma S; Boğa B; Kaçmaz M.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobuli…
Erçalışkan A; Avcı FZ; Eşkazan AE.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Proteomic Case Studies of MDS in Progression: Heterogeneity and More Heterogeneity
Pecankova K; Cermak J; Majek P.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia
Ren X; Tao Q; Wang H; Zhang Q; Zhou M; Liu L; Zhai Z.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated <i>NPM1</i>?
Cloobs-Venezia M; Dejesus J; Malusardi C; Auat M; Altube A.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Out…
Erdoğan E; Yalçın K; Hemşinlioğlu C; Sezgin A; Seyis U; Kançağı DD; Taştan C; Yurtsever B; Turan RD; Çakırsoy D; Abanuz S; Sır Karakuş G; Elek M; Bekoz HS; Gemici Aİ; Sargın D; Arat M; Ferhanoğlu B; Pekgüç E; Örnek S; Büyüktaş D; Birgen N; Ratip S; Ovalı E.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Initial Rate of <i>BCR::ABL1</i> Decline for Response Prediction in Chronic Myeloid Leukemia
Branford S.
Turk J Haematol (Unknown)
Published: 2022
1/6 Transparent
An Approach to Pediatric or Mentally Deficient Donors from a Bioethical Perspective: Considerations and Recommendations…
Keleş Ş; Boğa C; Tekkesin F; Özen İN; Kozanoğlu İ; the Turkish Society of Hematology’s Donor Research Team (DART).
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lympho…
Kayıkçı Ö; Mehtap Ö; Sarı İ; Demirkan F; Beyan C; Çetin G; Vural F; Yılmaz M; Öztürk E; Akpınar S; Eser B; Gündüz M; Büyükaşık Y; Payzın B; Yıldırım R; Doğu MH; Özkan A; Kelkitli E; Tekgündüz E.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Retraction: The <i>lnc-SNHG1</i> Gene Is Overexpressed and Correlates with Increased White Blood Cell Count, Poor Induc…
Zeng P; Chai Y; You C; Yue L; Wu C; Chen H; Li L; Li J; Liu H; Zhang Y; Cao T; Li Y; Hu W.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pseudo-Chediak-Higashi Granules in a Case of Acute Lymphoblastic Leukemia Mimicking Acute Myeloid Leukemia
Qiang X; Tao T; Chen X.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Hematopoietic Stem Cell Transplantation to a Patient with Acute Myeloid Leukemia from a Sibling Donor Positive for SARS…
Koç A; Doğru Ö; Eker N; Tufan Taş B; Şenay RE.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Combination of Haploidentical Hematopoietic Stem Cell Transplantation with Umbilical Cord-Derived Mesenchymal Stem Cell…
Sheng XF; Li H; Hong LL; Zhuang H.
Turk J Haematol (Unknown)
Published: 2022
3/6 Transparent
Funding Declared